Facebook
Instagram
Linkedin
Pinterest
Twitter
Youtube
Home
Safe Snack Guide
Peanut and Tree Nut Free Edition
Milk Free Edition
Sesame Free Edition
Gluten Free Edition
Custom Edition
Allergence
Coupons
About Us
Media Kit
Advertising Guide
Manufacturer Partnership
Subscribe to our newsletter
Contact Us
Resources
FAQ
Tools for Schools
Coupons
Search
Home
Safe Snack Guide
Peanut and Tree Nut Free Edition
Milk Free Edition
Sesame Free Edition
Gluten Free Edition
Custom Edition
Allergence
Coupons
About Us
Media Kit
Advertising Guide
Manufacturer Partnership
Subscribe to our newsletter
Contact Us
Resources
FAQ
Tools for Schools
Coupons
Search
Tag: eosinophilic esophagitis (EoE)
Increased Risk of EoE Linked to Antibiotic and Acid Suppressant Use...
Dave Bloom
-
2023/11/06
"There's clearly a correlation between early antibiotic use and atopic diseases like EoE."
Must Watch: Dr Kari Nadeau Teaches a Masterclass in Food Allergies...
Dave Bloom
-
2023/10/31
Required viewing for those suffering from food allergies and those who care for them.
Peptide Shows Promise as an Allergen-Agnostic Treatment for Food Allergy
Dave Bloom
-
2023/03/01
Revolog presents new data demonstrating long-lasting effect of '1104 candidate.
Esophageal String Test®, a Less Invasive Way to Monitor Adults and...
News Wire ~ 3rd Party Press Release
-
2022/10/24
Test offers EoE patients a simple, clinically proven method to control their disease.
Dupixent® Phase 3 Trial Shows Positive Results in Children Ages 1-11...
News Wire ~ 3rd Party Press Release
-
2022/07/15
Majority of patients achieved histological disease remission in 16 weeks.
Diagnosis of 12-Year-Old Boy with Gene Defect Leads to New Avenues...
Dave Bloom
-
2022/06/07
First description of the mutation in the human genome.
FDA Approves First Treatment for Eosinophilic Esophagitis (EoE), a Chronic Immune...
News Wire ~ 3rd Party Press Release
-
2022/05/23
EoE is a chronic inflammatory disorder in which eosinophils, a type of white blood cell, are found in the tissue of the esophagus.
FDA Accepts Dupixent® (dupilumab) for Priority Review in Patients Aged 12...
News Wire ~ 3rd Party Press Release
-
2022/04/12
If approved, Dupixent would be the first medicine available in the U.S. indicated to treat eosinophilic esophagitis.
CHOP Receives $2M Philanthropic Gift to Launch Food Allergy Study Using...
Dave Bloom
-
2021/11/18
"A successful clinical trial would open the possibility of food introduction to more than 3,500 CHOP patients with EoE."
Revolo Biotherapeutics Announces Open Enrollment for Phase 2 Clinical Trial of...
News Wire ~ 3rd Party Press Release
-
2021/10/28
Revolo Biotherapeutics announced it has activated clinical sites and opened enrollment in a Phase 2 clinical trial of its eosinophilic esophagitis therapy.
1
2
3
Page 1 of 3